+

WO2003034965A2 - Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement - Google Patents

Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement Download PDF

Info

Publication number
WO2003034965A2
WO2003034965A2 PCT/SE2002/001883 SE0201883W WO03034965A2 WO 2003034965 A2 WO2003034965 A2 WO 2003034965A2 SE 0201883 W SE0201883 W SE 0201883W WO 03034965 A2 WO03034965 A2 WO 03034965A2
Authority
WO
WIPO (PCT)
Prior art keywords
insert
sheet
skincare
spacing
skin
Prior art date
Application number
PCT/SE2002/001883
Other languages
English (en)
Other versions
WO2003034965A3 (fr
Inventor
Barbro Moberg-Alehammar
Bo Runeman
Ingemar Fernfors
Peter Rönnberg
Pontus Winqvist
Original Assignee
Sca Hygiene Products Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sca Hygiene Products Ab filed Critical Sca Hygiene Products Ab
Priority to AU2002363021A priority Critical patent/AU2002363021A1/en
Priority to JP2003537535A priority patent/JP2005506149A/ja
Priority to EP02802076A priority patent/EP1448144A2/fr
Priority to MXPA04002544A priority patent/MXPA04002544A/es
Publication of WO2003034965A2 publication Critical patent/WO2003034965A2/fr
Publication of WO2003034965A3 publication Critical patent/WO2003034965A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads

Definitions

  • An insert for use together with an absorbent article such as a diaper, an incontinence product, a panty liner or the like, which insert is substantially non-urine-absorbing, comprising a support sheet which has a first surface and a second surface, the first surface being treated with a skincare agent and the second surface being substantially impermeable to said skincare agent.
  • the surfaces which bear against the user's skin during use of the absorbent article are generally coated with, for example, creams, ointments, lotions or the like.
  • WO 96/16682 “Diaper having a lotioned topsheet” (Roe ef al) describes a diaper with lotion on the liquid-permeable topsheet. According to said document, problems such as poor intake of liquid are solved by using hydrophilic lotion on the topsheet. The lotion is said not to interact with, for example, urine in the same way that a hydrophobic lotion would do. The document also describes how cleaning the user's skin is made easier by the fact that the lotion is intended to be partially transferable to the user's skin in order, among other things, to prevent excrement from adhering to the skin. The diaper according to WO 96/16682 is also said to solve the problem of supplying therapeutic or protective components via the lotion, and small amounts of lotion which do not damage the liquid-handling capacity of the diaper and do not require special packaging.
  • the known diaper is associated with a number of problems.
  • any process in which lotion is added at high speed to a liquid-permeable material it is in principle impossible not to partially block at least some of the pores on the liquid-permeable topsheet. Attempts at avoiding or at any rate minimizing this problem can be made by applying the lotion in lines or specific patterns on the liquid-permeable topsheet. However, the problem of blocked pores still remains in the coating pattern.
  • a further problem is that lotion can migrate downwards from the topsheet through the pores and thereby prevent the absorption body from taking up liquid. This problem is remedied by producing lotions and lotion stabilizers with specific melt temperatures which preferably will be completely or at least partially solid at room temperature and will begin to melt preferably immediately below body temperature.
  • the product is exposed before use, for example during transportation and storage, to circumstances, such as more extreme temperatures, which mean that the lotion can still migrate at least partially and thus impair the intake of liquid into the absorbent article by blocking the pores of the topsheet and thus indirectly also the absorption core.
  • Migration of lotion to the absorption core can additionally cause a direct deterioration of the absorption capacity.
  • the migration problems arise, for example, when the product is kept in a hot storage area. It may also be hot in the shop where the product is for sale, the product may be left lying in a luggage boot on a sunny summer's day, a pack of diapers may be left in the laundry room above a radiator until the time comes to use the pack, etc.
  • there are obviously situations which cannot be safeguarded against merely by modifying the lotion so that it has a specific melt temperature.
  • WO 99/22684 "Web materials with two or more skin care compositions disposed thereon and articles made therefrom" (Roe et al) describes a web with at least two different kinds of skincare material.
  • the web is attached at different points to a diaper, for example the topsheet, the liquid barriers or the like.
  • no particular attention is paid to the problem of blocking of the pores.
  • the document also points to a lack of understanding of an important problem in connection with skin care; the skin where it is desired to prevent or treat skin irritations, sores, rashes or bedsores must preferably be as undisturbed as possible. This means that the skin should be exposed to the least possible external influence.
  • an absorbent article for example an incontinence product or diaper
  • Chafing means that the skin becomes more susceptible and more sensitive to the negative effects of excrement and urine and to the environments which result in a product when it is exposed to this.
  • the known insert is only designed to keep the skincare agent on the skin and there is no discussion at all of the risk of deteriorated intake of liquid which the insert itself causes because of the blocking of the topsheet.
  • nursing care problems such as bedsores caused by excessive loading of sensitive and perhaps damaged areas of the skin.
  • the invention is also aimed at solving the problem of the method of packaging in such a way that the lotion does not affect the absorbent article.
  • the invention makes it possible to obtain sufficient transfer of lotion without the lotion negatively affecting the intake of liquid into the absorbent article or the absorption capacity of the absorbent article.
  • There is a need for a solution making it possible to use lotion in an absorbent article or the like both in order to prevent and also to alleviate rashes, skin irritations, pressure sores, bedsores and the like.
  • the present invention has made available a substantially non-urine- absorbing insert which is of the type discussed in the introduction and which essentially eliminates the problems of the previously known inserts of this type.
  • An insert designed according to the invention is distinguished primarily by the fact that it also comprises at least one further sheet which functions as a spacing and liquid-receiving sheet placed against the second surface of the support sheet.
  • the arrangement of the spacing and liquid-receiving sheet facilitates the intake of liquid through the topsheet when the insert is in use.
  • Substantially non-urine-absorbing is to be understood as meaning that at least the so-called spacing and liquid-receiving sheet preferably will not retain any urine after wetting has occurred.
  • the spacing and liquid-receiving sheet must suitably transport liquid away, or at least should not to any great extent prevent liquid from reaching the absorption body.
  • it is in principle impossible to avoid a few drops of liquid being held in a fibre structure because of the capillary forces which arise in different cavities and between the fibres. However, this is not desirable and is minimized according to the invention.
  • the insert must therefore be substantially nonabsorbent in order to ensure that the pores or holes in the liquid-permeable topsheet will not be blocked and thus prevent liquid from penetrating into the absorption body and being absorbed by the core. Liquid must also be able to be transported through the topsheet upon repeated wetting.
  • the spacing sheet has a number of different functions. For example, as its name suggests, it is intended during use to separate the support sheet (which comprises at least one skincare agent and a barrier sheet) from the liquid-permeable topsheet.
  • the separating property is important to ensure that the topsheet (and thus indirectly also the absorption body) cannot be blocked by the barrier sheet. Liquid, for example urine or blood, must thus be able to pass beneath the barrier sheet in a free and relatively unimpeded manner. It is therefore also important for this reason that the spacing sheet is substantially non-urine-absorbing.
  • the spacing sheet is therefore preferably made of a material which is rigid, for example reticulated foam with an open pore structure.
  • the spacing sheet must therefore be liquid-permeable in at least one direction, i.e. in the X, Y or Z direction, preferably in all directions.
  • the spacing sheet can also be designed to make it easier in purely physical terms for liquid to penetrate through it, for example by means of channels parallel to the liquid-permeable topsheet of the absorbent article, elevations or depressions in specific zones, or other three-dimensional structures. On that surface of the spacing sheet which during use is intended to bear against the absorbent article, further material can also be attached so that " different three-dimensional structures are obtained.
  • chafing can in purely physical terms cause external damage to the skin, chafing also has the effect that the skin becomes more susceptible to other external influences such as excrement, urine and the extreme conditions which these cause.
  • the invention solves this problem by means of the fact that the insert attaches directly to the skin with the aid of the skincare agent. Preferably no paste or adhesive is therefore used, since this too can cause irritation upon repeated use or in cases of allergies, for example.
  • silicone gel is used as the securing means for the insert, as is described in more detail in GB-A- 2192 142 and EP-A1 -0,300,620.
  • Silicone gels are soft and attach to the skin. There are also silicone gels which do not attach to sores. The extremely low tendency to attach to sores, compared to other securing means, is due to the low surface tension of the silicone gel and to a surface chemistry which gives rise to another type of adhesion forces to sores than is obtained with an adhesive, for example. This means that the silicone gel is able to stick to tender, ulcered areas of the skin where adhesive would not be suitable as securing means.
  • silicone gel has a skincare effect and can be said to be a skincare agent per se.
  • the silicone gel can comprise further skincare agents or can be combined with a separate skincare agent.
  • the silicone gel can be applied in strips or patterns on the surfaces which are intended to be attached to the skin. In the last-mentioned design, the silicone gel is expediently placed across surfaces which are not covered with skincare agent, for example at the edges of the insert.
  • the insert After application, the insert is held in place with the aid of the outside absorbent article, for example a diaper, incontinence product, panty liner or the like, but without the insert being secured to the absorbent article.
  • That surface of the insert which during use is intended to bear against the absorbent article will preferably have as low a friction as possible against the absorbent article in order to minimize shearing forces which occur between the insert and the absorbent article and which can give rise to chafing of the user's skin.
  • the insert is thus free from the absorbent article in the sense that the insert is not secured to the absorent article during use but is only pressed against the skin by the absorbent article.
  • the insert is held in place by being secured to the skin with the aid of the skincare agent. This means that the surface exposed to shearing forces is shifted from the skin to the surface of the insert which during use bears against the absorbent article.
  • the risk of chafing of the user's skin has virtually been eliminated by means of the invention.
  • the spacing sheet is to some extent elastically compressible. This means that a desired property of the spacing sheet is that it can return to its original shape after loading. It must also be able to damp shocks or be conformable so that it retains its shape at least for a while after the load has ceased. It may also be desirable for the spacing sheet to be sufficiently rigid or pressure-resistant so that it is not compressed completely when loaded with a substantial weight. The aim of this is of course, as has already been mentioned, to ensure that the insert will be able to take up loads in specific areas of the skin which may be or may conceivably become exposed to discomforting and damaging loads. The shearing forces which can form between the absorbent article and the user can also be taken up or at least counteracted by a flexible material in the insert.
  • the spacing sheet consists of a material which recovers its shape after it has been exposed to loading.
  • the degree of recovery can be measured by a simple method:
  • the height Ho (thickness) of the material is measured.
  • the material is then exposed to a load of 200 kPa ( « 49.8 g /cm 2 ) for a defined period of time.
  • the height Hi is measured directly after the loading has ceased (directly means within about one minute).
  • the height H 2 is measured about 1 hour after the loading has ceased.
  • the height H 3 is measured about 4 hours after the loading has ceased.
  • the degree of recovery at different points in time can thus be calculated by (Hi/HoHOO, (H2/H0MOO or (H3 H 0 )»100. It may be difficult to obtain a reproducible measured value of the height directly after the loading has ceased (i.e. within one minute) for a material which recovers quickly. It is therefore important that the height is measured after the same length of time for each sample. If the first sample is measured after about 15 seconds, it is important to ensure that the following sample is also measured after about 15 seconds, in order to obtain a value which is as reproducible as possible.
  • a Mitutoyo® ID-U1025 can be used, for example, to obtain a precise value of the height. The important point, however, is that the height is measured in the same manner for all heights, so that a reproducible value is obtained.
  • the spacing sheet consists of a material which has a degree of recovery of about 70-100%, preferably 50-100% and most preferably 20-100% directly after the loading has ceased. Moreover, the degree of recovery is expediently about 70-100%, preferably 50-100% and most preferably 20-100% about 1 hour after the loading has ceased, and expediently about 70-100%, preferably 50-100% and most preferably 20- 100% about 4 hours after the loading has ceased.
  • the spacing sheet is made of a material which has a free volume (or void volume) of 1-95% of the total volume of the insert.
  • a spacing sheet with a free volume of over 40% of the total volume of the insert is highly porous with cavities in the material.
  • a sufficiently porous material functions as a distribution sheet which makes it easier, for example, for urine to be absorbed by the core since the topsheet is not blocked.
  • Another advantage of a highly porous spacing and liquid-receiving sheet is that a large quantity of liquid can be received in a short time.
  • the support sheet consists of a separate skincare sheet and a barrier sheet, the barrier sheet being placed between the skincare sheet and the spacing sheet.
  • the support sheet in this case has a multiplicity of holes or pores and has an effective open area of at least 10%, the open area of the holes or pores being at least 0.1 mm 2 per hole or pore.
  • Effective open area is to be understood as the sum of the open area of the individual holes in relation to the area of the first surface of the support sheet. Open area is to be understood as that area of the hole or pore which lies in the same plane as the first surface of the support sheet).
  • the area of the holes and thus the effective open area can be varied.
  • the skincare agent should therefore be sticky, that is to say sticky enough to ensure that the insert remains on the skin and does not fall off directly after application.
  • the use of adhesive or the like as securing means should be avoided since adhesive often gives rise to skin irritation or allergic reactions upon repeated use. It is therefore preferable for the skincare agent itself to be able to function as the substance for securing the insert to the skin.
  • the viscosity of the skincare agent is in some cases a measure of how sticky the skincare agent can be. If the viscosity is too high, so that the skincare agent is completely solid in consistency, it will not function as a means of securing the insert.
  • One of the advantages of the invention is that it permits a greater viscosity range for the skincare agent than is possible when, for example, lotion or the like is applied to the topsheet of a diaper, since the skincare agent can be coated on and/or impregnated in the support sheet.
  • the invention is also distinguished by the fact that it is possible to arrange a large quantity of skincare agent on the support sheet.
  • a large quantity of skincare agent ensures a good transfer and a continuous transfer.
  • the support sheet expediently comprises at least 0.1 mg of skincare agent per cm 3 of support sheet.
  • Fig. 1 shows an insert comprising support sheet and spacing sheet
  • Fig. 2 shows an insert with a specific design of the support sheet
  • Fig. 3 shows an insert with a specific design of a coating of skincare agent
  • Fig. 4 shows an insert with a specific design of the spacing sheet
  • Fig. 5 shows a person, seen from behind, with an insert secured to the skin before the absorbent article is applied,
  • Fig. 6 shows a person, seen from the side, with an insert secured to the skin before the absorbent article is applied, and
  • Fig. 7 shows a person lying supine with an insert secured to the skin and an absorbent article around the waist and hip region.
  • the insert 1 shown in Fig. 1 comprises a support sheet 2 and a spacing sheet 3 which together have a generally elongate form.
  • the two sheets 2, 3 each have two longitudinal sides 4, 5 and two transverse sides 6, 7, a longitudinal centre line 8 and a transverse centre line 9.
  • the support sheet 2 moreover has a first thickness 10 and the spacing sheet has a second thickness 11.
  • the support sheet 2 according to Fig. 1 has a first surface and a second surface 12, 13, the first surface 12 being treated with a skincare agent 14.
  • the skincare agent 14 can be applied to the top of the first surface 12 and forms a topsheet 15, can be impregnated in the first surface 12 or applied so that the skincare agent 14 completely or partially migrates into the first surface 12 and thus also partially into the support sheet 10.
  • the first surface 12 can also be called the skincare surface 12.
  • the second surface 13 of the support sheet 2 is substantially impermeable to the skincare agent 14 and can be obtained by a modification of the material, such as heat treatment, pore gradient, change of surface energy or the like, and can also be called barrier sheet.
  • the support sheet 2 can also consist of a laminate in which the skincare surface 12 consists of at least one individual sheet.
  • the second surface 13 of the support sheet can also consist of at least one individual sheet.
  • the support sheet 2 can also consist of at least two connected laminates.
  • the support sheet 2 and the spacing sheet 3 can consist of a number of different materials, for example the support sheet 2 and the spacing sheet 3 can consist of a nonwoven, a woven material, film, foam, elastic web or combinations of these.
  • Preferred sheet materials can include polyolefins, for example polyethylene including linear low-density polyethylene (LLDPE), low-density polyethylene (LDPE), ultra-low-density polyetheylene (ULDPE), high-density polyethylene (HDPE), or polypropylene and/or mixtures of said materials.
  • LLDPE linear low-density polyethylene
  • LDPE low-density polyethylene
  • ULDPE ultra-low-density polyetheylene
  • HDPE high-density polyethylene
  • polypropylene polypropylene and/or mixtures of said materials.
  • suitable polymeric materials which could be used are polyesters, polyurethanes, compostable or biodegradable polymers, heat-sensitive polymers, thermoplastic elastomers, metalycene catalyst- based polymers (for example InsiteTM which is commercially available from DOW Chemicals and ExxactTM which is commercially available from Exxon), and breathable polymers or vapour-permeable (breathable) material.
  • the web can also consist of or comprise a synthetic web, perforated nonwoven or film, macroscopically expanded three-dimensional films, foam material, filled composiitons or laminates and/or combinations of these.
  • Nonwoven material can be produced by being what is called spun-bonded, liquid perforated, liquid entangled, carded, air-bonded, calendered or combinations of these.
  • the support sheet 2 and the spacing sheet 3 are substantially non-urine-absorbing (the insert may in some circumstances retain very small quantities of liquid) and the material of at least the spacing and liquid-receiving sheet should therefore consist of a substantially hydrophobic material, for example synthetic fibres such as polyolefin fibres which have not been treated with wetting agent.
  • the support sheet 2 and the spacing sheet 3 can also be laminates of previously mentioned materials combined in a number of ways known in the art.
  • the support sheet 2 and the spacing sheet 3 can also be joined together for example by thermal binding, adhesion, for example with spray adhesive, hotmelt, latex-based adhesive or the like, ultrasound welding, or extruder lamination, which involves a polymer film being laid directly on a substrate while the film is still in the partially melted state and thereby adheres to the substrate.
  • Said laminates can consist of one or more sheets of elastic layers, preferably compression-elastic and/or nonelastic layers.
  • the support sheet and the spacing sheet consist of a single sheet and that the skincare agent is applied to the first surface of the sheet and that the barrier part consists of a section positioned between said first surface and the second surface of the sheet.
  • the support sheet 2 is impregnated and/or coated with a skincare agent 14 such as a lotion or the like which, during use, secures the insert 1 to the user's skin in such a way that the skincare agent 14 is afterwards partially transferred to the user.
  • a skincare agent 14 such as a lotion or the like which, during use, secures the insert 1 to the user's skin in such a way that the skincare agent 14 is afterwards partially transferred to the user.
  • FIG. 2 A further embodiment of the insert 1 is shown in Fig. 2, comprising a support sheet 2 and a spacing sheet 3 which together have a generally elongate form.
  • the two sheets 2, 3 also each have two longitudinal sides 4, 5 and two transverse sides 6, 7, a longitudinal centre line 8 and a transverse centre line 9.
  • the support sheet additionally has a first thickness 10 and the spacing sheet has a second thickness 11.
  • the support sheet 2 in Fig. 2 has a number of through-holes 16 which extend through the entire thickness 10 of the support sheet 2.
  • the support sheet 2 comprises a skincare sheet 15 and a barrier sheet 17 which is substantially impermeable to the skincare agent 14. It is possible, within the scope of the invention, that the holes 16 do not go through the barrier sheet 17, which in that case preferably consists of a substantially vapour-permeable material. It is also possible, within the scope of the invention, that the holes 16 extend through the whole insert, i.e. that the holes 16 go through both the thickness
  • a further embodiment of the insert 1 is shown in Fig. 3 and comprises a support sheet 2 and a spacing sheet 3 which together have a generally elongate form.
  • the two sheets 2, 3 each have two longitudinal sides 4, 5 and two transverse sides 6, 7, a longitudinal centre line 8 and a transverse centre line 9.
  • the support sheet additionally has a first thickness 10 and the spacing sheet has a second thickness 11.
  • Fig. 3 shows the skincare agent 14 arranged in the form of a rectangle 18 on the first surface 12 of the support sheet.
  • the rectangle 18 is coated on the first surface 12 of the support sheet such that the area of the applied skincare agent 14 is smaller than the area of the first surface 12 of the support sheet and such that there is a remaining area 19 around the rectangle 18 not coated with skincare agent.
  • the area of the skincare agent 14 is substantially the same size as the area of the first surface 12 of the support sheet 2.
  • the skincare agent 14 can be applied in a number of different shapes, i.e. it does not need to be a rectangle.
  • the skincare agent 14 can be applied in a circular shape or rhomboid shape, the skincare agent 14 could have three, four, five or more edges, and irregular shape, but also a number of other shapes.
  • the skincare agent 14 can also be in different patterns such as squares, stripes, dots, circles, simple pictures of objects, logos, animals, plants or the like.
  • the spacing sheet 3 can have a number of different designs.
  • the thickness 11 of the spacing sheet 3 can, for example, be smaller than, larger than or the same size as the thickness 10 of the support sheet 2.
  • the thickness 11 of the spacing sheet 3 can also be different at different locations of the spacing sheet 3, i.e. there can be a certain three-dimensional structure.
  • three-dimensional structures can be formed which make this easier, for example channels or the like which run parallel to the liquid- permeable topsheet of the absorbent article.
  • the spacing sheet 3 can recover its original shape after loading, and that it will be able to have a shock-damping function or be conformable so that the spacing sheet 3 retains its shape at least for a while after the loading has ceased. It can also be desirable that the spacing sheet 3 is sufficiently rigid and pressure-resistant to ensure that it is not completely compressed when loaded with a considerable weight. This is of course, as has already been mentioned, to ensure that the insert will, during use, relieve the load on specific areas of the skin which may be or may conceivably become exposed to discomforting and/or damaging load. It is also important that the spacing and liquid-receiving sheet of the insert can receive liquid under a certain loading.
  • FIG. 4 A further embodiment of the insert 1 is shown in Fig. 4, comprising a support sheet 2 and a spacing sheet 3 which together have a generally elongate form.
  • the two sheets 2, 3 each have two longitudinal sides 4, 5 and two transverse sides 6, 7, a longitudinal centre line 8 and a transverse centre line 9, and the support sheet has a first thickness 10 and the spacing sheet has a second thickness 11.
  • the spacing sheet 3 has a channel 20 which extends substantially in the direction of the longitudinal centre line 8 of the insert.
  • the channel 20 can be produced by compression of the spacing sheet 3, hollowing-out material, or by attaching further material along the longitudinal sides 4, 5 of the spacing sheet 3. It is also possible, within the scope of the invention, to arrange a number of channels extending either in the direction of the longitudinal centre line 8 of the insert 1 or the transverse centre line 9 of the insert 1. Other types of patterns are also conceivable, for example circular, square or the like. The most important point is that the configuration of the spacing sheet 3 is such that intake of liquid through or past the spacing sheet 3 is facilitated.
  • Fig. 5 shows a user, seen from behind, with an insert 51 secured to the skin.
  • Fig. 6 shows the same user seen from one side.
  • the insert is secured to one of the user's buttocks, although the insert can in principle be secured at any position on the user which is to be treated or where treatment is to be avoided. After the insert has been secured, the absorbent article is applied to the user in the customary manner.
  • the insert can have a rectangular shape as in Figs. 5 and 6, but it is also possible within the scope of the invention for the insert to have another shape, such as a shape with three or more edges, oval, circular, rhomboid, irregular or similar shape.
  • the insert can also have the shape of a vehicle, house, plant, figure, or any other shape which it may be imagined could be desirable.
  • the size of the insert can also be varied, for example the skincare side of the insert can have an area of about 2-500 cm 2 , preferably 40-350 cm 2 , most preferably 80-200 cm 2 .
  • the size of the insert can if necessary be adapted depending on the type of treatment desired, the person who is to use the insert, and the type and size of the absorbent article. There may even be advantages to be gained in terms of production engineering by designing the insert in a specific way, for example in order to minimize wastage during manufacture of the insert.
  • the shape of the insert can be varied depending on where it is intended to be placed on the user. As it is within the scope of the invention for the insert to be placed anywhere on the body, and specifically to the inside of the absorbent article, it can be important that the insert is made available in different sizes and shapes. A general rule of thumb should be that large inserts are used for large treatment surfaces and small inserts for small treatment surfaces, or alternatively a number of small inserts for a large treatment surface. Treatment surface is to be understood as meaning the surface of the user's skin which is intended to be treated with the skincare agent.
  • Fig. 7 shows a person with a bedsore (pressure sore) lying supine.
  • An insert 52 is applied on one leg and buttock.
  • the insert 52 extends slightly outside the absorbent article 53 and thus affords, in addition to a good skincare effect, a support and relief from the leakage barriers 54 of the absorbent article 53.
  • Leakage barriers are often found in the leg area of absorbent articles such as diapers or incontinence products. Examples of absorbent articles with leakage barriers (also called liquid barriers) are described in, for example, WO-A1 -9207533, US 4695278, US 5064489, SE-T3-0264238 and GB-A-2188532.
  • the insert can also afford support and relief at the waist or at other locations where the absorbent article may conceivably be to tight or give rise to uncomfortable chafing.
  • the insert extends in across the liquid-permeable topsheet (not shown in the figure) of the absorbent article 53.
  • Dermatitis is best prevented by creating conditions which counteract those factors which create and maintain the process of diaper dermatitis. It should therefore be endeavoured to keep the skin as dry as possible, to air the skin often and to change wet diapers. Mechanical shearing forces should be minimized by choosing materials which are as smooth and soft as possible, and wear between diaper and skin should be minimized.
  • a softening and protective lotion or cream By supplying the skin with a softening and protective lotion or cream, it is further possible to strengthen the barrier against penetration of irritant substances and enzymes. In more serious cases of dermatitis, microorganisms may have infected the damaged skin, and treatment with more active medicines is required. Ointments with cortisone and various fungicidal and bactericidal agents are then used.
  • Skincare agents can be used to prevent, alleviate or heal dermatitis.
  • a skincare agent can consist, in its physical form, of a solution, suspension, cream, lotion, ointment, paste, gel, foam, aerosol or capsule, or it can be present in solid phase as particles, flakes, fibres, films, foams, waddings, sticks, etc.
  • a cream, lotion or ointment is preferably used, but others of the above-described forms are of course also conceivable.
  • Skincare agents can include lipids (fats, oils, waxes), solvents (including water), water-soluble substances, surface-active agents (emulsifiers, surfactants), viscosity-regulating substances, pH-regulating substances, preserving agents, complexing agents (e.g. chelates), delivery systems (e.g.
  • the lipids are usually emulsified in water, known as o/w emulsion, or water is emulsified in the lipid phase, known as w/o emulsion.
  • Skincare agents can include lipids such as: paraffins (alkanes) with 12-35 carbon, for example paraffin oil (mineral oil) or petrolatum (vaseline).
  • paraffins alkanes
  • mineral oil mineral oil
  • petrolatum valine
  • Triglycerides refined and/or hydrogenated, animal or vegetable with preferably carbon chain lengths of under C-18 (e.g. milk fat, coconut oil Cocous nocifera, palm-kernel oil Elaeis guineeis), animal or vegetable with unsaturated C-18 fatty acids (e.g.
  • Polyalcohols For example, sugar alcohols or polyglycerols.
  • Complex lipids For example, phospholipids or sphingolipids (ceramides).
  • Waxes Of animal origin, for example beeswax or lanolin. Of vegetable origin, for example carnauba or candelilla. Of mineral origin, for example ozocerite or ceresin.
  • Polysiloxanes Straight, branched or cyclic.
  • polydimethyl- siloxane dimethyl-siloxane
  • polydiethylsiloxane polydimethyl- siloxane (dimethicone) or polydiethylsiloxane.
  • Skincare agents can include emulsions such as: Emulsions of one or more fats with hydrophilic substances such as water, glycerol, polyethylene glycol (PEG), propylene glycol, butylene glycol, sorbitol, silicone glycols or the like or mixtures thereof.
  • hydrophilic substances such as water, glycerol, polyethylene glycol (PEG), propylene glycol, butylene glycol, sorbitol, silicone glycols or the like or mixtures thereof.
  • Skincare agents can include substances which adsorb irritating components in urine or excrement.
  • clay mineral bentonite, kaolin, montmorillonite, etc
  • silicon oxide compounds quartz, zeolites, water glass, etc
  • activated charcoal The substances can advantageously have been activated to be more adsorbent by means of various treatments, for example with quaternary ammonium compounds.
  • Skincare agents can include enzyme inhibitors. For example, metal salts of iron or zinc, trace amounts of heavy metal ions such as copper or silver, ethylene diamine tetraacetic acid (EDTA), soybean trypsin inhibitor, lima bean protease inhibitor, maize protease inhibitor, stearylglycyrrhetinate, glycerol triacetate, betaine compounds, sulphobetaine compounds, cholestyramine, p-guanidinobenzoates.
  • Skincare agents can include pH-regulating additives. For example, organic or inorganic acids such as adipic acid, ascorbic acid, benzoic acid, citric acid, malic acid, tartaric acid, lactic acid, phosphoric acid or hydrochloric acid. Or buffers made for example from said acids with corresponding salts. Can also include polymeric acids, for example polyphosphoric acid or polyacrylic acid.
  • Skincare agents can also include additions of probiotic microorganisms, characterized by being antagonistic towards undesired microorganisms, e.g. urinary tract pathogens or skin infection pathogens.
  • probiotic microorganisms which can be used are individual strains or mixtures of several strains of lactic acid bacteria taken from the species Lactobacillus acidophilus, Lactobacillus curvatus, Lactobacillus plantarum or Lactococis lactis.
  • Skincare agents can also include more or less active substances such as: Anti-inflammatory agents, e.g. acetylsalicylic acid, allantoin, azulen, alpha- bisabolol (chamomile), flavonoids, glycyrrhizinic acid, ichthammol (Inotyol®), tannins.
  • Astringents vasoconstrictors
  • aluminium acetate solution aluminium tartrate solution (and other Al compounds)
  • ethanol or ethanol-based solutions ethanol-based solutions.
  • Aloe vera Aloe barbadensis
  • alpha-hydroxy acids citric acid, tartaric acid, lactic acid, malic acid, etc.
  • algae extract ascorbic acid (vitamin C)
  • vitamin A compounds retinol, retinal, tretinoin and isotretinoin
  • avocado sterols betaine (trimethylglycine), ceramides, grapeseed extract, essential fatty acids, flavonoids, phytosphingosine, phytosterols, hyaluronic acid, yeast extract, chitosan, milk protein (Lactis proteinum), pantenol (provitamin B5), polysaccharides, rosemary extract, tocopherol (vitamin E), ubiquinone (coenzyme Q10), urea.
  • Antimicrobial agents for example amorolfin, antibiotics, bacitracin, benzalkonium chloride, benzetonium chloride, cetrimide, fusidic acid, gentian violet (methylrosaniline chloride), hexachlorophene, hexylresorcinol, imidazole derivatatives (for example biphonazole, econazole, ketoconazole, chlotrimazole, miconazole), chlorhexidine, nystatin, povidone-iodine, terbinafin, triclosan, hydrogen peroxide.
  • Antiviral agents for example acyclovir, imiquimod, podophyllotoxin, podophilox, cidofovir, penciclovir, vidarabin, idoxuridine, trifluridine, tromantadine, lamivudine.
  • Skincare agents can also include glucocorticoids, preferably of low potency, for example hydrocortisone, or antipruritic, for example antihistamines or local anaesthetics (e.g. lidocaine).
  • glucocorticoids preferably of low potency, for example hydrocortisone, or antipruritic, for example antihistamines or local anaesthetics (e.g. lidocaine).
  • Skincare agents can also consist of ready-made mixtures of skin ointments, creams and lotions.
  • Necesse® Lotion (ingredients: aqua, propylene glycol, liquid paraffin, octyl octanoate, urea, PEG-8 distearate, steareth-2, steareth-21 , betaine, lactic acid, tocopheryl acetate, dimethicone, tromethamine, methylparaben, propylparaben, perfume), Necesse® Skin
  • Cream (ingredients: aqua, liquid paraffin, octyl stearate, sodium chloride, urea, glyceryl stearate, stearic acid, cetearyl alcohol, PEG-30 stearate, tocopheryl acetate, tromethamine, dimethicone, methylparaben, sorbic acid, propylparaben, perfume), Necesse® Barrier Cream (ingredients: petrolatum, glycerol, Arachis hypogaea, triethyl citrate, tocopheryl acetate) or Necesse®
  • Zinc Ointment (ingredients: petrolatum, Arachis hypogaea, zinc oxide, retinyl palmitate, tocopherol).
  • Necesse® products are sold commercially by SCA
  • WO 96/16682 Diaper having a lotioned topsheet
  • WO 96/16681 Diaper having a lotioned topsheet containing a polysiloxane emmollient
  • WO 97/05909 Diaper having a lotioned topsheet comprising a liquid polyester emollient and an immobilizing agent
  • WO 99/45973 Disosable absorbent article having a skin care composition containing an enzyme inhibitor” (Roe et al.), WO 99/45974 "Protease inhibitors in absorbent products” (Rourke et al.), WO 99/45976 "Proton donating actives in absorbent articles” (McOsker et al.), DE 33 09 530 C1 "Hygienische Absorptionsvorlage"
  • the invention is not limited to the skincare agents just mentioned and that instead these are just examples of what could be used.
  • the invention will preferably not make use of completely solid compositions of skincare agents since the aim is that the skincare agent will to some extent secure the insert to the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

L'invention concerne une garniture à utiliser avec un article absorbant tel qu'une couche, un article d'incontinence, une serviette hygiénique, un protège-slip ou analogue. Ladite garniture est sensiblement imperméable à l'urine et comprend une feuille de support (2) dotée d'une première (12) et d'une seconde (13) surfaces - la première surface étant traitée à l'aide d'un agent (14) de soins pour la peau et la seconde surface (13) étant sensiblement imperméable à cet agent (14) - d'une ligne centrale (8) longitudinale et d'une ligne centrale (9) transversale. Cette garniture comprend également au moins une feuille (3) d'écartement et de réception de liquide placée contre la seconde surface de la feuille de support (2). La feuille d'écartement et de réception de liquide facilite l'absorption du liquide à travers la feuille supérieure lorsqu'on utilise ladite garniture.
PCT/SE2002/001883 2001-10-26 2002-10-16 Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement WO2003034965A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002363021A AU2002363021A1 (en) 2001-10-26 2002-10-16 Insert for an absorbent article with skincare agent and spacing sheet
JP2003537535A JP2005506149A (ja) 2001-10-26 2002-10-16 スキンケア剤及びスペーシングシートを有する吸収物品のためのインサート
EP02802076A EP1448144A2 (fr) 2001-10-26 2002-10-16 Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement
MXPA04002544A MXPA04002544A (es) 2001-10-26 2002-10-16 Insercion para un articulo absorbente con agente protector de la piel y separador.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103567A SE520236C2 (sv) 2001-10-26 2001-10-26 Inlägg till absorberande artikel med hudvårdande medel och distansskikt
SE0103567-4 2001-10-26

Publications (2)

Publication Number Publication Date
WO2003034965A2 true WO2003034965A2 (fr) 2003-05-01
WO2003034965A3 WO2003034965A3 (fr) 2003-10-02

Family

ID=20285778

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2002/001883 WO2003034965A2 (fr) 2001-10-26 2002-10-16 Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement

Country Status (7)

Country Link
EP (1) EP1448144A2 (fr)
JP (1) JP2005506149A (fr)
AU (1) AU2002363021A1 (fr)
MX (1) MXPA04002544A (fr)
PL (1) PL368508A1 (fr)
SE (1) SE520236C2 (fr)
WO (1) WO2003034965A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060224A1 (fr) * 2002-12-31 2004-07-22 Kimberly-Clark Worldwide, Inc. Article secondaire impregne d'une lotion
FR2858225A1 (fr) * 2003-07-28 2005-02-04 Oreal Article cosmetique de traitement de la peau, des muqueuses, des cheveux ou du cuir chevelu et procede de traitement cosmetique.
US10058462B2 (en) 2006-05-04 2018-08-28 Sca Hygiene Products Ab Multi function wrapper
US10058629B2 (en) 2005-12-01 2018-08-28 Sca Hygiene Products Ab Absorbent article with skin care agent composition immobilized in a lipid phase

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4815183B2 (ja) * 2005-10-05 2011-11-16 王子ネピア株式会社 褥瘡用シート
CA2630881A1 (fr) * 2005-11-29 2007-06-07 Ambria Dermatology Ab Utilisation d'une composition comprenant pentane-1, 5-diol comme deodorant
JP6067974B2 (ja) * 2012-02-28 2017-01-25 ユニ・チャーム株式会社 創傷部被覆材を備える二次ドレッシング材

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348547A (en) * 1993-04-05 1994-09-20 The Procter & Gamble Company Absorbent members having improved fluid distribution via low density and basis weight acquisition zones
US5643588A (en) * 1994-11-28 1997-07-01 The Procter & Gamble Company Diaper having a lotioned topsheet
US6120783A (en) * 1997-10-31 2000-09-19 The Procter & Gamble Company Web materials with two or more skin care compositions disposed thereon and articles made therefrom
DE29819087U1 (de) * 1998-10-27 2000-03-09 Schulz, Klaus, Dr.med., 50259 Pulheim Pad oder Windeleinlage zur Trennung der zur Pflege oder Therapie auf die Haut aufgetragenen Substanzen und der Windelinnenlage
EP1051958A1 (fr) * 1999-05-14 2000-11-15 The Procter & Gamble Company Article absorbant jetable ayant une couche supérieure hydrophobe et une capacité améliorée à retenir un liquide
JP3805159B2 (ja) * 2000-01-25 2006-08-02 ユニ・チャーム株式会社 皮膚保護成分を含んだ吸収性物品
JP2002085451A (ja) * 2000-05-10 2002-03-26 Uni Charm Corp 油性成分を含んだ層を有するシート、および前記シートを用いた製品

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060224A1 (fr) * 2002-12-31 2004-07-22 Kimberly-Clark Worldwide, Inc. Article secondaire impregne d'une lotion
US7491863B2 (en) 2002-12-31 2009-02-17 Kimberly-Clark Worldwide, Inc. Secondary lotioned article
FR2858225A1 (fr) * 2003-07-28 2005-02-04 Oreal Article cosmetique de traitement de la peau, des muqueuses, des cheveux ou du cuir chevelu et procede de traitement cosmetique.
EP1512390A1 (fr) * 2003-07-28 2005-03-09 L'oreal Article cosmétique de traitement de la peau, des muqueuses, des cheveux ou du cuir chevelu et procédé de traitement cosmétique
US10058629B2 (en) 2005-12-01 2018-08-28 Sca Hygiene Products Ab Absorbent article with skin care agent composition immobilized in a lipid phase
US10058462B2 (en) 2006-05-04 2018-08-28 Sca Hygiene Products Ab Multi function wrapper

Also Published As

Publication number Publication date
SE0103567L (sv) 2003-04-27
WO2003034965A3 (fr) 2003-10-02
PL368508A1 (en) 2005-04-04
SE0103567D0 (sv) 2001-10-26
JP2005506149A (ja) 2005-03-03
EP1448144A2 (fr) 2004-08-25
SE520236C2 (sv) 2003-06-10
MXPA04002544A (es) 2004-06-18
AU2002363021A1 (en) 2003-05-06

Similar Documents

Publication Publication Date Title
EP1455710B1 (fr) Article absorbant et son procede de production
US7938812B2 (en) Insert for an absorbent article with skincare agent and spacing sheet
EP1605981B1 (fr) Tampon de traitement d'hemorroides
EP2103315B1 (fr) Serviettes hygiéniques avec lotions hydrophobes
EP1858463A1 (fr) Article absorbant comprenant une couche barriere bloquant le passage de la composition pour le soin de la peau
US20040102750A1 (en) Absorbent article with a body facing liner having discretely placed lotion deposits
MX2008011419A (es) Articulos absorbentes con lociones.
US8795716B2 (en) Skin care compositions on a thin sanitary napkin
WO2000064501A1 (fr) Articles absorbants doux pour la peau et compositions associees
US20060069370A1 (en) Absorbent article having a liner with areas that prevent lotion and adhesive migration
WO2003034965A2 (fr) Garniture inseree entre un article absorbant et la peau comprenant un agent de soins pour la peau et une feuille d'ecartement
US20080300563A1 (en) Absorbent Article with Improved Elastic Means
RU2394542C2 (ru) Поглощающее изделие с усовершенствованными эластичными средствами
AU2002327797B2 (en) Sanitary napkins with hydrophobic lotions
AU2002327797A1 (en) Sanitary napkins with hydrophobic lotions
AU2007200811A1 (en) Sanitary napkins with hydrophobic lotions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/002544

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1-2004-500519

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2003537535

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002802076

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002802076

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载